Search Results

PF-4981517 25mg  | 98%

APEXBIO TECHNOLOGY LLC

CYP3A4 inhibitor,potent and selective Metabolism|P450

More Information Supplier Page

×

PF-4981517

PF-4981517 10mg  | 98%

APEXBIO TECHNOLOGY LLC

CYP3A4 inhibitor,potent and selective Metabolism|P450

More Information Supplier Page

×

PF-4981517

PF-4981517 5mg  | 98%

APEXBIO TECHNOLOGY LLC

CYP3A4 inhibitor,potent and selective Metabolism|P450

More Information Supplier Page

×

PF-4981517

Rosiglitazone HCl 200mg  | 99.31%

APEXBIO TECHNOLOGY LLC

PPARγ agonist Metabolism|PPAR

More Information Supplier Page

×

Rosiglitazone HCl

GW501516 10mg  | 98.27%

APEXBIO TECHNOLOGY LLC

PPARδ agonist,selective and potent Metabolism|PPAR

More Information Supplier Page

×

GW501516

GW501516 50mg  | 98.27%

APEXBIO TECHNOLOGY LLC

PPARδ agonist,selective and potent Metabolism|PPAR

More Information Supplier Page

×

GW501516

GW501516 100mg  | 98.27%

APEXBIO TECHNOLOGY LLC

PPARδ agonist,selective and potent Metabolism|PPAR

More Information Supplier Page

×

GW501516

Rosiglitazone HCl 25mg  | 99.31%

APEXBIO TECHNOLOGY LLC

PPARγ agonist Metabolism|PPAR

More Information Supplier Page

×

Rosiglitazone HCl

Rosiglitazone HCl 100mg  | 99.31%

APEXBIO TECHNOLOGY LLC

PPARγ agonist Metabolism|PPAR

More Information Supplier Page

×

Rosiglitazone HCl

GW501516 5mg  | 98.27%

APEXBIO TECHNOLOGY LLC

PPARδ agonist,selective and potent Metabolism|PPAR

More Information Supplier Page

×

GW501516